SCHEMBL16201982

SCHEMBL16201982

Cc1ccn(-c2ccc(F)cc2F)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.53
RAB9A P51151 3/20 0.53
MAPT P10636 3/20 0.53
ALDH1A1 P00352 3/20 0.53
KDM4E B2RXH2 2/20 0.53
TDO2 P48775 1/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
NPC1 O15118 2/20 0.42
ATM Q13315 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
OPRM1 P35372 1/20 0.39
HTT P42858 3/20 0.38
GLA P06280 1/20 0.38
KCNN3 Q9UGI6 1/20 0.37
GRM5 P41594 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
SCD O00767 1/20 0.36
PHGDH O43175 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16201981 0.86 MAPT (0.53) GAARAB9AMAPTALDH1A1KDM4E
SCHEMBL14412227 0.83 MAPT (0.58) GAARAB9AMAPTALDH1A1KDM4E
SCHEMBL29542168 0.83 MAPT (0.50) GAARAB9AMAPTALDH1A1KDM4E
SCHEMBL16201984 0.83 GAA (0.50) GAARAB9AMAPTALDH1A1KDM4E
SCHEMBL2627212 0.83 MAPT (0.50) GAARAB9AMAPTALDH1A1KDM4E
SCHEMBL997672 0.83 ALDH1A1 (0.50) GAARAB9AMAPTALDH1A1KDM4E
SCHEMBL29542723 0.79 GAA (0.50) GAARAB9AMAPTALDH1A1KDM4E
SCHEMBL8485618 0.79 RAB9A (0.46) GAARAB9AMAPTALDH1A1KDM4E
SCHEMBL2357923 0.79 ALDH1A1 (0.41) GAARAB9AALDH1A1L3MBTL1NPC1
SCHEMBL29571818 0.79 ALDH1A1 (0.41) GAARAB9AALDH1A1L3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160249615-A1 Use of Strobilurin Type Compounds for Combating Phytopathogenic Fungi Resistant to QO Inhibitors BASF SE (DE) 2016-09-01 US disclosed
US-20160145219-A1 STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI BASF SE (DE) 2016-05-26 US disclosed
US-20160145202-A1 Strobilurin Type Compounds for Combating Phytopathogenic Fungi BASF SE (DE) 2016-05-26 US disclosed
US-20160122327-A1 STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI BASF SE (DE) 2016-05-05 US disclosed
US-9271501-B2 Use of strobilurin type compounds for combating phytopathogenic fungi resistant to QO inhibitors BASF SE (DE) 2016-03-01 US disclosed
CN-104245715-A Blue luminescent compounds DU PONT 2014-12-24 CN disclosed
US-20140323305-A1 Use of Strobilurin Type Compounds for Combating Phytopathogenic Fungi Resistant to QO Inhibitors BASF SE (DE) 2014-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160122327-A1 STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI SNX1, DPM1, SNU13 GAA 244/4885RAB9A 2110/4885MAPT 1798/4885
US-20160145219-A1 STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI DPM1, CROCC, SNX1 GAA 192/4885RAB9A 2327/4885MAPT 1392/4885
US-20160145202-A1 Strobilurin Type Compounds for Combating Phytopathogenic Fungi DPM1, CROCC, SNX1 GAA 192/4885RAB9A 2327/4885MAPT 1392/4885
US-20140323305-A1 Use of Strobilurin Type Compounds for Combating Phytopathogenic Fungi Resistant to QO Inhibitors SQOR, COX5B, UQCRB GAA 633/4885RAB9A 1342/4885MAPT 2644/4885
US-20160249615-A1 Use of Strobilurin Type Compounds for Combating Phytopathogenic Fungi Resistant to QO Inhibitors SQOR, COX5B, UQCRB GAA 633/4885RAB9A 1342/4885MAPT 2644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.